Article

EGFR TKI Combined with PD1 Inhibitor for EGFR Mutated Lung Cancer with Breast Metastasis

2021-04-19

Abstract excerpt

<h4>Background: </h4> Lung adenocarcinoma with breast metastasis is rare. In the present study, a case of an advanced patient with breast metastasis from lung adenocarcinoma with EGFR 21 exon p.L858R mutation who underwent EGFR TKI combined with PD1 inhibitor is reported. Case presentation A 62-year-old female patient diagnosed with lung adenocarcinoma who had undergone six times disease progress and breast metast...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 09404eb6-6fb2-5203-99b8-ead56101abd8
DOI: 10.21203/rs.3.rs-431147/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

EGFR TKI Combined with PD1 Inhibitor for EGFR Mutated Lung Cancer with Breast MetastasisDOI 10.21203/rs.3.rs-431147/v1Read

Almonertinib in the treatment of lung cancer with breast metastasis: a case reportSemantic proximity Read

Lung Adenocarcinoma with Metachronous Ovarian Metastasis: a long survival case reportSemantic proximity Read

Comprehensive diagnosis and individualized treatment of multiple primary lung cancers: a case reportSemantic proximity Read

Successful Treatment For a Young Patient With Multiple Synchronous Breast And Lung Carcinoma: A Case ReportSemantic proximity Read

Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review.Semantic proximity Read

Response to furmonertinib in a patient with non-Small cell lung cancer harboring HER2 exon 21 insertion mutation : a case reportSemantic proximity Read

Ado-trastuzumab emtansine in the treatment of lung adenocarcinoma with ERBB2 mutation: a case report and literature review.Semantic proximity Read

The prognostic analysis of non-small cell lung cancer with unexpected pleural cavity disseminationSemantic proximity Read

First-line treatment for driver gene–negative metastatic lung adenocarcinoma with malignant pleural effusion: Should chemotherapy be combined with an immune checkpoint inhibitor or bevacizumab？Semantic proximity Read

Lung Adenocarcinoma With Primary LIMD1-BRAF Fusion Treated With MEK Inhibitor: A Case Report.Semantic proximity Read

A Rare Case of Breast Metastasis from a Primary Lung Tumor: Case ReportSemantic proximity Read

Chemotherapeutic Agents Increase PD-L1 Expression in A549 Lung Cancer Cell LineSemantic proximity Read